4,4'-Di-O-methylellagic acid

4,4'-Di-O-methylellagic acid
Product Name 4,4'-Di-O-methylellagic acid
CAS No.: 3374-77-4
Catalog No.: CFN92805
Molecular Formula: C16H10O8
Molecular Weight: 330.0 g/mol
Purity: >=98%
Type of Compound: Phenols
Physical Desc.: Powder
Targets: Wnt/β-catenin
Source: The peels of Punica granatum L.
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price:
4,4'-di-O-methylellagic acid is the most effective compound in the inhibition of colon cancer cell proliferation.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Molecules.2023, 28(8):3474.
  • Functional Ecology2020, doi: 10.1111.
  • Biomolecules.2024, 14(5):589.
  • Cells.2023, 12(3):395.
  • Int. J. Mol. Sci. 2022, 23(3),1696.
  • Biomed Pharmacother.2020, 131:110673.
  • Int J Oncol.2016, 49(4):1497-504
  • J Clin Transl Hepatol.2023, 11(4):863-876.
  • J Med Food.2016, 19(12):1155-1165
  • Molecules.2020, 25(9):2111.
  • 3-O-Methylducheside A

    Catalog No: CFN97069
    CAS No: 62218-23-9
    Price: Inquiry(manager@chemfaces.com)
    3,3'-Di-O-methylellagic acid 4'-glucoside

    Catalog No: CFN90830
    CAS No: 51803-68-0
    Price: $413/5mg
    2,3,8-Tri-O-methylellagic acid

    Catalog No: CFN99680
    CAS No: 1617-49-8
    Price: $318/5mg
    3,7-Di-O-methylducheside A

    Catalog No: CFN99426
    CAS No: 136133-08-9
    Price: Inquiry(manager@chemfaces.com)
    Nyssoside

    Catalog No: CFN99851
    CAS No: 182138-70-1
    Price: Inquiry(manager@chemfaces.com)
    Punicalin

    Catalog No: CFN98113
    CAS No: 65995-64-4
    Price: $218/20mg
    Punicalagin

    Catalog No: CFN99938
    CAS No: 65995-63-3
    Price: $108/20mg
    Terchebulin

    Catalog No: CFN92297
    CAS No: 132854-40-1
    Price: Inquiry(manager@chemfaces.com)
    Ellagic acid-4-O-beta-D-xylopyranoside

    Catalog No: CFN95618
    CAS No: 139163-18-1
    Price: $318/5mg
    Ellagic acid 4-O-alpha-L-arabinofuranoside

    Catalog No: CFN95613
    CAS No: 358617-39-7
    Price: $318/5mg
    J Pharmacol Exp Ther. 2015 May;353(2):433-44.
    The ellagic acid derivative 4,4'-di-O-methylellagic acid efficiently inhibits colon cancer cell growth through a mechanism involving WNT16.[Pubmed: 25758919]
    Ellagic acid (EA) and some derivatives have been reported to inhibit cancer cell proliferation, induce cell cycle arrest, and modulate some important cellular processes related to cancer. This study aimed to identify possible structure-activity relationships of EA and some in vivo derivatives in their antiproliferative effect on both human colon cancer and normal cells, and to compare this activity with that of other polyphenols.
    METHODS AND RESULTS:
    Our results showed that 4,4'-Di-O-methylellagic acid (4,4'-DiOMEA) was the most effective compound in the inhibition of colon cancer cell proliferation. 4,4'-DiOMEA was 13-fold more effective than other compounds of the same family. In addition, 4,4'-DiOMEA was very active against colon cancer cells resistant to the chemotherapeutic agent 5-fluoracil, whereas no effect was observed in nonmalignant colon cells. Moreover, no correlation between antiproliferative and antioxidant activities was found, further supporting that structure differences might result in dissimilar molecular targets involved in their differential effects. Finally, microarray analysis revealed that 4,4'-DiOMEA modulated Wnt signaling, which might be involved in the potential antitumor action of this compound.
    CONCLUSIONS:
    Our results suggest that structural-activity differences between EA and 4,4'-DiOMEA might constitute the basis for a new strategy in anticancer drug discovery based on these chemical modifications.
    3''-Galloylquercitrin

    Catalog No: CFN95048
    CAS No: 503446-90-0
    Price: $368/5mg
    Shancigusin I

    Catalog No: CFN95061
    CAS No: 1435488-35-9
    Price: Inquiry(manager@chemfaces.com)
    Macrophylloside D

    Catalog No: CFN95113
    CAS No: 179457-69-3
    Price: $318/10mg
    4-Hydroxybenzoyl choline

    Catalog No: CFN95158
    CAS No: 5094-31-5
    Price: $318/20mg
    Polygalasaponin XXXV

    Catalog No: CFN95176
    CAS No: 184479-28-5
    Price: $463/5mg
    2-Methoxy-5-acetoxy-furanogermacr-1(10)-en-6-one

    Catalog No: CFN95197
    CAS No: 1809980-25-3
    Price: $318/10mg
    trans-Psoralenoside

    Catalog No: CFN95349
    CAS No: N/A
    Price: $318/5mg
    Malabaricone A

    Catalog No: CFN95477
    CAS No: 63335-23-9
    Price: $318/10mg
    Ganoderic acid GS-2

    Catalog No: CFN95549
    CAS No: 1206781-65-8
    Price: $413/5mg
    Methyl ganoderate F

    Catalog No: CFN95584
    CAS No: 98665-08-8
    Price: $368/5mg